Sign in

CIK 0000872589

  • Large accelerated filer

REGENERON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
REGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NY
Entity type
Operating
EIN
133444607
Phone
+1 914-847-7000
Business address
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
Former names
REGENERON PHARMACEUTICALS INC
  1. 4 Open-market sale Director sold 2,084 shares at $549.00 ($1,144,116)
  2. 4 Open-market sale President and Chief Scientific sold 80,000 shares at an average $538.90 ($43,112,141)
  3. 4 Open-market sale Director sold 100 shares at an average $524.76 ($52,476)
  4. 4 Open-market sale Director sold 1,700 shares at $525.00 ($892,500)
  5. 4 Open-market sale Director sold 1,930 shares at $525.00 ($1,013,250)
  6. 4 Open-market sale EVP Commercial sold 1,000 shares at $511.65 ($511,650)
  7. 4 Open-market sale EVP Research and Development sold 17,521 shares at an average $519.46 ($9,101,460)
  8. 4 Open-market sale EVP Commercial sold 1,000 shares at $495.63 ($495,630)
  9. 4 Shares withheld for taxes Director gave up 137,998 shares (to pay taxes)
  10. 4 Insider Changes in Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale Director sold 100 shares at an average $506.92 ($50,692)
  13. 4 Open-market sale Director sold 2,480 shares at $554.32 ($1,374,714)
  14. 4 Grant or award Director acquired 248 shares (grant or award)
  15. 4 Grant or award Director acquired 248 shares (grant or award)
  16. 4 Grant or award Director acquired 248 shares (grant or award)
  17. 4 Grant or award Director acquired 248 shares (grant or award)
  18. 4 Grant or award Director acquired 248 shares (grant or award)
  19. 4 Grant or award Director acquired 248 shares (grant or award)
  20. 4 Grant or award Director acquired 248 shares (grant or award)

Page 22 of 77 · 1,533 filings